Effect of plasma-derived or recombinant factor VIII on inhibitor development. A systematic review

被引：0
|
作者：
Iorio, A.
Halimeh, S.
Bidlingmaier, C.
Ettingshausen, C. E.
Gringeri, A.
Holzhauer, S.
Knoefler, R.
Kreuz, W.
Kurnik, K.
Manner, D.
Santagostino, E.
Mannucci, P. M.
Nowak-Goettl, U.
机构：
来源：
HAEMOPHILIA | 2010年 / 16卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：410 / 410
页数：1
相关论文
共 50 条
  • [1] Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review
    Iorio, A.
    Halimeh, S.
    Goldenberg, N.
    Kenet, G.
    Young, G.
    Brandao, L.
    HAEMOPHILIA, 2010, 16 : 74 - 74
  • [2] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
    BRAY, G
    ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34
  • [3] Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
    Iorio, A.
    Halimeh, S.
    Holzhauer, S.
    Goldenberg, N.
    Marchesini, E.
    Marcucci, M.
    Young, G.
    Bidlingmaier, C.
    Brandao, L. R.
    Ettingshausen, C. E.
    Gringeri, A.
    Kenet, G.
    Knoefler, R.
    Kreuz, W.
    Kurnik, K.
    Manner, D.
    Santagostino, E.
    Mannucci, P. M.
    Nowak-Goettl, U.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1256 - 1265
  • [4] Inhibitor development and efficacy of recombinant vs. plasma-derived factor VIII concentrates in haemophilia A patients
    Siegmund, B.
    Richter, H.
    Pollmann, H.
    Orlovic, M.
    Gottstein, S. .
    Klamroth, R.
    HAEMOPHILIA, 2008, 14 : 51 - 51
  • [5] Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
    Peyvandi, F.
    Cannavo, A.
    Garagiola, I.
    Palla, R.
    Mannucci, P. M.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (01) : 39 - 43
  • [6] Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2010, 8 (04) : 288 - 291
  • [7] Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
    Lin, Y
    Yang, X
    Chevrier, MC
    Craven, S
    Barrowcliffe, TW
    Lemieux, R
    Ofosu, FA
    HAEMOPHILIA, 2004, 10 (05) : 459 - 469
  • [8] Plasma-derived versus recombinant factor VIII for the treatment of hemophilia A
    Kasper, CK
    VOX SANGUINIS, 1996, 70 : 17 - 20
  • [9] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
  • [10] Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
    Lai, Jesse
    Hough, Christine
    Tarrant, Julie
    Lillicrap, David
    BLOOD, 2017, 129 (24) : 3147 - 3154
12345